User:Immcarle116/Macrophage-1 antigen/Bibliography

From Wikipedia, the free encyclopedia

Bibliography[edit]

The following are articles/review articles to consider in completing the WIKI assignment:

[1] Review - 2019: Expression levels and other functional differences of CR3 in mice and men assessed.

[2] Review - 2018: A look at the structural and cellular immunology of CR3 giving insights on its biochemistry and functions.

[3] Review - 2003: Regulation of CR3 during injury/disease in CNS and PNS.

[4] Review - 2007

[5] Review - 1993: ICAM-1 and LPS.

[6] Article - 2016: CR3 Agonist Leukadherin‐1.

[7] Article - 2019: CR3 engagement with PGL-I and Leprosy.

[8] ? - 2006: Gram-negative bacteria could takes advantage of CR3.

[9] Review - 2016: Immunoregulatory roles of CR3


  1. ^ Erdei, Anna; Lukácsi, Szilvia; Mácsik-Valent, Bernadett; Nagy-Baló, Zsuzsa; Kurucz, István; Bajtay, Zsuzsa (2019). "Non-identical twins: Different faces of CR3 and CR4 in myeloid and lymphoid cells of mice and men". Seminars in Cell & Developmental Biology. 85: 110–121. doi:10.1016/j.semcdb.2017.11.025.
  2. ^ Vorup-Jensen, Thomas; Jensen, Rasmus Kjeldsen (2018-11-26). "Structural Immunology of Complement Receptors 3 and 4". Frontiers in Immunology. 9: 2716. doi:10.3389/fimmu.2018.02716. ISSN 1664-3224. PMC 6275225. PMID 30534123.{{cite journal}}: CS1 maint: PMC format (link) CS1 maint: unflagged free DOI (link)
  3. ^ Rotshenker, Shlomo (2003). "Microglia and Macrophage Activation and the Regulation of Complement-Receptor-3 (CR3/MAC-1)-Mediated Myelin Phagocytosis in Injury and Disease". Journal of Molecular Neuroscience. 21 (1): 65–72. doi:10.1385/JMN:21:1:65. ISSN 0895-8696.
  4. ^ van Lookeren Campagne, Menno; Wiesmann, Christian; Brown, Eric J. (2007). "Macrophage complement receptors and pathogen clearance". Cellular Microbiology. 9 (9): 2095–2102. doi:10.1111/j.1462-5822.2007.00981.x.
  5. ^ Ross, G. D.; Větvička, V. (1993). "CR3 (CD11b, CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functions". Clinical & Experimental Immunology. 92 (2): 181–184. doi:10.1111/j.1365-2249.1993.tb03377.x. PMC 1554824. PMID 8485905.{{cite journal}}: CS1 maint: PMC format (link)
  6. ^ Roberts, A. L.; Fürnrohr, B. G.; Vyse, T. J.; Rhodes, B. (2016). "The complement receptor 3 (CD11b/CD18) agonist Leukadherin-1 suppresses human innate inflammatory signalling: CR3 agonist suppresses inflammatory signaling". Clinical & Experimental Immunology. 185 (3): 361–371. doi:10.1111/cei.12803. PMC 4991522. PMID 27118513.{{cite journal}}: CS1 maint: PMC format (link)
  7. ^ Doz-Deblauwe, Émilie; Carreras, Florence; Arbues, Ainhoa; Remot, Aude; Epardaud, Mathieu; Malaga, Wladimir; Mayau, Véronique; Prandi, Jacques; Astarie-Dequeker, Catherine; Guilhot, Christophe; Demangel, Caroline (2019-12-17). "CR3 Engaged by PGL-I Triggers Syk-Calcineurin-NFATc to Rewire the Innate Immune Response in Leprosy". Frontiers in Immunology. 10: 2913. doi:10.3389/fimmu.2019.02913. ISSN 1664-3224. PMC 6928039. PMID 31921172.{{cite journal}}: CS1 maint: PMC format (link) CS1 maint: unflagged free DOI (link)
  8. ^ Agramonte-Hevia, José; González-Arenas, Aliesha; Barrera, Diana; Velasco-Velázquez, Marco (2002-12-01). "Gram-negative bacteria and phagocytic cell interaction mediated by complement receptor 3". FEMS Immunology & Medical Microbiology. 34 (4): 255–266. doi:10.1111/j.1574-695X.2002.tb00640.x. ISSN 0928-8244.
  9. ^ Rosetti, Florencia. Mayadas, Tanya N. The many faces of Mac-1 in autoimmune disease. OCLC 1053723142.{{cite book}}: CS1 maint: multiple names: authors list (link)

//

This is where you will compile the bibliography for your Wikipedia assignment. Please refer to the following resources for help: